TRVI EBITDA Growth
Trevi Therapeutics Inc · EBITDA Growth
TRVI EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-8.15%period ending
TRVI TTM EBITDA YoY % (-57.72% → -8.15%)
Year-over-year change
High-resolution chart · PNG
TRVI ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -8.1493% | |
| 3.576% | |
| 10.6987% | |
| -3.4891% | |
| -22.163% | |
| -41.8391% | |
| -67.2008% | |
| -69.622% | |
| -46.5888% | |
| -22.7885% | |
| -2.1478% | |
| 15.8186% | |
| 11.9067% | |
| 14.3187% | |
| 14.4517% | |
| 8.1273% | |
| 11.96% | |
| 0.7183% | |
| -1.351% | |
| -13.7373% | |
| -14.2146% | |
| -7.0877% | |
| -23.6466% | |
| -15.7619% | |
| -24.4655% | |
| -42.6313% | |
| -30.3746% | |
| -57.7205% |